Tesamorelin 10mg

Tesamorelin 10mg

Core metabolic/body comp effects
• Significant reduction in visceral adipose tissue (VAT) in HIV‑associated lipodystrophy, typically around 10–20% VAT reduction over ~6 months versus placebo in randomized trials.
• Little change in subcutaneous fat, meaning selective action on deep, metabolically active abdominal fat rather than global fat loss.
• Preservation or slight increase in lean muscle mass, in contrast to caloric restriction alone where lean mass often drops.

Cardiometabolic benefits
• Improvements in triglycerides and non‑HDL cholesterol have been observed, alongside increases in adiponectin, which supports better fat and glucose metabolism.
• Reductions in liver fat (hepatic fat fraction) and prevention of visceral fat gain have been reported in patients on modern integrase‑inhibitor HIV regimens.
• Overall metabolic profile shifts toward lower inflammatory and cardiometabolic risk, though long‑term cardiovascular outcome data are still limited.

Mechanism and GH/IGF‑1 related effects
• Synthetic growth‑hormone–releasing hormone (GHRH) analogue that stimulates pituitary GH secretion and raises IGF‑1 within physiological feedback constraints.
• Compared with exogenous GH, this upstream stimulation supports a more physiologic pulsatile pattern of GH, which may reduce some side‑effect risks associated with flat GH exposure.
• Improved GH/IGF‑1 signaling is linked to better tissue repair, bone maintenance, and overall vitality, though these outcomes are inferred from GH biology more than tesamorelin‑specific long‑term trials.

Cognitive and quality‑of‑life signals
• A 20‑week clinical trial in older adults (with and without mild cognitive impairment) found favorable effects of tesamorelin on measures of executive function and memory compared with placebo.
• Reviews of GH/IGF‑1 biology report that both hormones play major roles in adult brain function, and age‑related decline in IGF‑1 appears to precede cognitive decline, supporting a plausible neurocognitive upside.
• Many clinical and wellness reports note improved energy, mood, sleep quality, and recovery, but these are mostly patient‑reported outcomes rather than rigorously quantified endpoints.